Autoimmunity in Neurologic Complications of Celiac Disease
The Role of Autoimmunity in Neurologic Complications of Celiac Disease
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Listed as NCT00692861, this observational or N/A phase trial focuses on Ataxia and remains completed. Sponsored by National Institute of Neurological Disorders and Stroke (NINDS), it has been updated 18 times since 2008, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
18 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jan 2020 — Jan 2021 [monthly]
Completed
-
Dec 2019 — Jan 2020 [monthly]
Completed
▶ Show 13 earlier versions
-
Nov 2019 — Dec 2019 [monthly]
Completed
-
Aug 2019 — Nov 2019 [monthly]
Completed
-
Apr 2019 — Aug 2019 [monthly]
Completed
-
Mar 2019 — Apr 2019 [monthly]
Completed
-
Jan 2019 — Mar 2019 [monthly]
Completed
-
Dec 2018 — Jan 2019 [monthly]
Completed
-
Oct 2018 — Dec 2018 [monthly]
Completed
-
Sep 2018 — Oct 2018 [monthly]
Completed
-
Aug 2018 — Sep 2018 [monthly]
Completed
-
Jul 2018 — Aug 2018 [monthly]
Completed
-
Jun 2018 — Jul 2018 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Jun 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Neurological Disorders and Stroke (NINDS)
For direct contact, visit the study record on ClinicalTrials.gov .